Endocrinology / diabetes clinical trials recruiting in California

530 recruiting endocrinology / diabetes trials match in California. Showing 20.

• PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting

  Phase 1 · PanTher Therapeutics · Newport Beach, California

• A Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesRecruiting

  Phase 1 · RasCal Therapeutics, Inc. · Los Angeles, California

• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)Recruiting

  Phase 3 · Amgen · Fountain Valley, California

• A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsRecruiting

  Phase 1 · Angiex, Inc. · Los Angeles, California

• Use of CGM in Kidney Transplant RecipientsRecruiting

  N/A · University of California, Davis · Sacramento, California

• Family, Responsibility, Education, Support, and Health for Food ResponsivenessRecruiting

  N/A · University of California, San Diego · La Jolla, California

• A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsRecruiting

  Phase 1 / Phase 2 · Day One Biopharmaceuticals, Inc. · Orange, California

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruiting

  Phase 1 · IDEAYA Biosciences · Santa Rosa, California

• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting

  N/A · Massive Bio, Inc. · Duarte, California

• Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsRecruiting

  Phase 1 · Xencor, Inc. · Duarte, California

• Registry for Stage 2 Type 1 DiabetesRecruiting

  N/A · Sanofi · Los Angeles, California

• 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CTRecruiting

  Phase 2 / Phase 3 · Andrei Iagaru · Stanford, California

• Diabetes RElated to Acute Pancreatitis and Its MechanismsRecruiting

  N/A · Milton S. Hershey Medical Center · Los Angeles, California

• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)Recruiting

  Phase 3 · Daiichi Sankyo · Burbank, California

• Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube CancerRecruiting

  Phase 3 · GOG Foundation · Duarte, California

• A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainRecruiting

  Phase 3 · Novo Nordisk A/S · Walnut Creek, California

• Latinos Understanding the Need for Adherence in Diabetes Using E-HealthRecruiting

  N/A · San Diego State University · Chula Vista, California

• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruiting

  Phase 1 / Phase 2 · Children's Oncology Group · Los Angeles, California

• Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial CancerRecruiting

  Phase 2 · Jonsson Comprehensive Cancer Center · Los Angeles, California

• AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian CancerRecruiting

  Phase 3 · AstraZeneca · Birmingham, Alabama

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.